This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PharMerica Completes Certification With Surescripts To Support Real-Time Electronic Prescribing By Physicians In Long-Term Care Settings

PharMerica Corporation (NYSE:PMC), a leading institutional pharmacy, specialty infusion and hospital services company servicing healthcare facilities in the United States, today announced that it has been certified by Surescripts to receive controlled and non-controlled substance prescription orders electronically. PharMerica’s e-prescribing solution is the most user friendly, accessible and open e-prescribing solution in the long-term care pharmacy industry.

PharMerica’s e-prescribing service will allow physicians to electronically send prescriptions to any PharMerica pharmacy nationwide, using the same computer software in their offices today. Physicians will require no additional training or new hardware to submit electronic prescriptions to PharMerica. Physician’s using the e-prescribing service will substantially reduce the time it takes for patients to receive their medication while streamlining a previously manual, paper-based process. In addition to improving health outcomes, e-prescribing streamlines the process for complying with Drug Enforcement Administration policies for dispensing controlled substances in the long-term care setting.

Greg Weishar, PharMerica Corporation’s Chief Executive Officer, said, “We are confident that bringing pharmacy industry standards to the long-term care industry will lead to faster rates of adoption. The Surescripts’ network is convenient, efficient and economical for the physician community. Surescripts, the nation’s largest clinical health information network, will allow us to better serve all trading partners in our collective pursuit of delivering outstanding pharmacy service and quality patient care.”

About PharMerica

PharMerica Corporation is a leading institutional pharmacy services company that services healthcare facilities in the United States, provides pharmacy management services to hospitals, and also provides specialty infusion services to patients outside a hospital setting. As of March 31, 2013, PharMerica operated 89 institutional pharmacies and 12 specialty infusion centers in 45 states. PharMerica's customers are institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care, and other long-term alternative care providers.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs